These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Markers of liver function and inflammatory cytokines modulation by aerobic versus resisted exercise training for nonalcoholic steatohepatitis patients. Abd El-Kader SM; Al-Jiffri OH; Al-Shreef FM Afr Health Sci; 2014 Sep; 14(3):551-7. PubMed ID: 25352871 [TBL] [Abstract][Full Text] [Related]
4. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis. Idilman R; Mizrak D; Corapcioglu D; Bektas M; Doganay B; Sayki M; Coban S; Erden E; Soykan I; Emral R; Uysal AR; Ozden A Aliment Pharmacol Ther; 2008 Jul; 28(2):200-8. PubMed ID: 18445142 [TBL] [Abstract][Full Text] [Related]
5. The benefits of exercise for patients with non-alcoholic fatty liver disease. Keating SE; George J; Johnson NA Expert Rev Gastroenterol Hepatol; 2015; 9(10):1247-50. PubMed ID: 26289101 [TBL] [Abstract][Full Text] [Related]
6. Aerobic exercise and non-alcoholic fatty liver disease: a case report. Di Mauro D; Pagano F; Magaudda L; Speciale F; Speranza G; Bonaiuto M; Mallamace A; Trimarchi F J Sports Med Phys Fitness; 2009 Dec; 49(4):448-52. PubMed ID: 20087305 [TBL] [Abstract][Full Text] [Related]
7. Red blood cell distribution width as a non-invasive marker for the assessment of inflammation in non-alcoholic steatohepatitis. Dogan S; Celikbilek M; Zararsiz G; Deniz K; Sivgin S; Guven K; Gursoy S; Ozbakir O; Yucesoy M Hepatogastroenterology; 2015; 62(138):393-8. PubMed ID: 25916070 [TBL] [Abstract][Full Text] [Related]
8. Effect of enforced physical inactivity induced by 60-day of bed rest on hepatic markers of NAFLD in healthy normal-weight women. Rudwill F; Bergouignan A; Gastebois C; Gauquelin-Koch G; Lefai E; Blanc S; Simon C Liver Int; 2015 Jun; 35(6):1700-6. PubMed ID: 25413107 [TBL] [Abstract][Full Text] [Related]
9. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. Sreenivasa Baba C; Alexander G; Kalyani B; Pandey R; Rastogi S; Pandey A; Choudhuri G J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):191-8. PubMed ID: 16706832 [TBL] [Abstract][Full Text] [Related]
10. Involvement of hepatic peroxisome proliferator-activated receptor α/γ in the therapeutic effect of osthole on high-fat and high-sucrose-induced steatohepatitis in rats. Zhao X; Xue J; Wang XL; Zhang Y; Deng M; Xie ML Int Immunopharmacol; 2014 Sep; 22(1):176-81. PubMed ID: 24993341 [TBL] [Abstract][Full Text] [Related]
11. Liver Disease in Adolescents. Ovchinsky N; Kogan-Liberman D Adolesc Med State Art Rev; 2016; 27(1):75-92. PubMed ID: 27363234 [No Abstract] [Full Text] [Related]
12. Combination of Aspartate Aminotranferase and Tumor Necrosis Factor-α as Non Invasive Diagnostic Tools for Non Alcoholic Steatohepatitis (NASH). Purnomo HD; Mundhofir FE; Kasno ; Sudijanto E; Darmono ; Daldiyono ; Djokomoeljanto R; Faradz SM Acta Med Indones; 2015 Jan; 47(1):16-23. PubMed ID: 25948763 [TBL] [Abstract][Full Text] [Related]
13. A non-invasive prediction model for non-alcoholic steatohepatitis in paediatric patients with non-alcoholic fatty liver disease. Eng K; Lopez R; Liccardo D; Nobili V; Alkhouri N Dig Liver Dis; 2014 Nov; 46(11):1008-13. PubMed ID: 25106814 [TBL] [Abstract][Full Text] [Related]
14. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Sorbi D; Boynton J; Lindor KD Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476 [TBL] [Abstract][Full Text] [Related]
15. Effect of resveratrol on experimental non-alcoholic steatohepatitis. Heebøll S; Thomsen KL; Clouston A; Sundelin EI; Radko Y; Christensen LP; Ramezani-Moghadam M; Kreutzfeldt M; Pedersen SB; Jessen N; Hebbard L; George J; Grønbæk H Pharmacol Res; 2015; 95-96():34-41. PubMed ID: 25814186 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Williams CD; Stengel J; Asike MI; Torres DM; Shaw J; Contreras M; Landt CL; Harrison SA Gastroenterology; 2011 Jan; 140(1):124-31. PubMed ID: 20858492 [TBL] [Abstract][Full Text] [Related]
17. Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement. Koot BG; van der Baan-Slootweg OH; Tamminga-Smeulders CL; Rijcken TH; Korevaar JC; van Aalderen WM; Jansen PL; Benninga MA Arch Dis Child; 2011 Jul; 96(7):669-74. PubMed ID: 21518734 [TBL] [Abstract][Full Text] [Related]
18. [Aspartate-ornithine granules in the treatment of nonalcoholic steatohepatitis: a multiple-dose parallel controlled clinical trial]. Tian LY; Lu LG; Tang CW; Xie Y; Luo HS; Tan SY; Pang Z; Zhang YL; Gong LB; Li YM; Chen SH; Shi JP Zhonghua Gan Zang Bing Za Zhi; 2013 Jul; 21(7):528-32. PubMed ID: 24074713 [TBL] [Abstract][Full Text] [Related]
19. [Management of asymptomatic elevated serum aminotransferase levels, particularly in nonalcoholic steatohepatitis]. Oldenburg B; Van Berge Henegouwen GP Ned Tijdschr Geneeskd; 1999 Mar; 143(10):506-9. PubMed ID: 10321258 [TBL] [Abstract][Full Text] [Related]